NCT01990209 2022-06-30
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
SCRI Development Innovations, LLC
Phase 2 Completed
Clinical Trials
5 trialsNCT01816048 2019-12-09
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis
University of Wisconsin, Madison
Phase 2 Terminated
NCT02101684 2018-03-05
Greko II
Grupo EspaƱol de Tumores HuƩrfanos e Infrecuentes
Phase 2 Terminated
NCT01866423 2017-08-31
Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
University of Southern California
Phase 2 Terminated
NCT03211052 2017-07-07
NEPTUNE
Queen Mary University of London
Phase 2 Terminated